Safety, tolerability, and efficacy of PBT2 in Huntington's disease: A phase 2, randomised, double-blind, placebo-controlled trial

Pharmacology, Toxicology and Pharmaceutical Science

• Tolerability 100%
• Huntington Chorea 100%
• Placebo 100%
• Adverse Event 22%
• Suicide Attempt 22%
• Mouse Model 11%
• Efficacy Assessment 11%
• Acute Coronary Syndrome 11%
• Virus Infection 11%
• Major Depression 11%
• Huntingtin 11%
• Subdural Hematoma 11%

Medicine and Dentistry

• Huntington's Disease 100%
• Placebo 100%
• Trail Making Test 33%
• Adverse Event 22%
• Suicide Attempt 22%
• Virus Infection 11%
• Executive Function 11%
• Intention-to-Treat Analysis 11%
• Acute Coronary Syndrome 11%
• Major Depressive Episode 11%
• Symbol Digit Modalities Test 11%
• Efficacy Assessment 11%
• Montreal Cognitive Assessment 11%
• Subdural Hematoma 11%
• Reading Test 11%
• Huntingtin 11%
• Least Squares Method 11%